Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.82−0.17 (-8.42%)
Close on Nov 17, 2026Market cap $2.65MP/E –Yield –
Nexentis Technologies total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nexentis Technologies's total debt was $215.00K at Jun 30, 2026. For fiscal 2025 it was $1.42M, up 8350.5% from the year before. The highest annual figure on record is $1.42M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42M | +8350.5% |
| FY2021 | Dec 31, 2021 | $16.78K | -30.1% |
| FY2020 | Dec 31, 2020 | $24.01K | -18.4% |
| FY2019 | Dec 31, 2019 | $29.42K | -65.0% |
| FY2018 | Dec 31, 2018 | $83.95K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $215.00K | -82.5% |
| Q1 FY2026 | Mar 31, 2026 | $364.00K | +55814.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.42M | +18.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.22M | +65777.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.23M | +32690.8% |
| Q1 FY2025 | Mar 31, 2025 | $651 | -89.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.20M | +7051.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.86K | -76.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.75K | -52.7% |
| Q1 FY2022 | Mar 31, 2022 | $6.20K | -19.6% |
| Q4 FY2021 | Dec 31, 2021 | $16.78K | -30.1% |
| Q3 FY2021 | Sep 30, 2021 | $8.05K | -52.2% |
| Q2 FY2021 | Jun 30, 2021 | $7.93K | -57.2% |
| Q1 FY2021 | Mar 31, 2021 | $7.71K | -61.0% |
| Q4 FY2020 | Dec 31, 2020 | $24.01K | -18.4% |
| Q3 FY2020 | Sep 30, 2020 | $16.84K | -79.9% |
| Q2 FY2020 | Jun 30, 2020 | $18.53K | – |
| Q1 FY2020 | Mar 31, 2020 | $19.77K | – |
| Q4 FY2019 | Dec 31, 2019 | $29.42K | – |
| Q4 FY2018 | Dec 31, 2018 | $83.95K | – |
See a number that looks wrong?